The modern-day management of erectile dys-function reflects a host of advances that have
occurred in the field of sexual medicine, particularly in the past several years. In the …

DRAMATIC ADVANCES IN THE MANAGEMENT of erectile dysfunction have occurred over
the past decade. Oral therapy with vasoactive agents has emerged as first-line treatment …

Erectile dysfunction (ED) is defined as the consistent or recurrent inability to attain or
maintain penile erection sufficient for sexual performance. 1 Self-reported ED has increased …

Abstract Phosphodiesterase type-5 (PDE-5) inhibitors have revolutionized the treatment of
post-radical prostatectomy erectile dysfunction. For those patients who undergo a non-nerve …

Introduction Treatment of erectile dysfunction is based on pharmacotherapy for most
patients. Aim To review the current data on pharmacotherapy for erectile dysfunction based …

There are new and novel therapies emerging in the field of erectile dysfunction, both
centrally acting and peripherally acting agents delivered orally, intracavernosally or …

Erectile dysfunction (ED) is the persistent inability to achieve or maintain an erection
sufficient for satisfactory sexual performance. 1 According to data from the Massachusetts …

It is widely accepted that disorders of the male (uro) genital tract, such as erectile dysfunction
(ED) and benign diseases of the prostate (lower urinary tract symptomatology or benign …

While the outcome of current pharmacotherapy of erectile dysfunction (ED) is generally
satisfactory, there remain a significant number of men who fail to respond adequately to …

The advancement and refinement in prostate cancer detection and treatment modalities
have contributed to a younger patient population undergoing radical prostatectomy (RP)(1) …